AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Rallybio Corporation

$16.88 +$11.21 (+198.14%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$16.75
Day Range
$16.7$16.88
Year Range
$3.67$17.57
Market Cap
89.55M
AVG Volume
69.68K
Trailing/Forward PE
2.13/-
PEG ratio
0.02
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0250K500K750K1M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RLYB Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q2646K
26 Q1858K
25 Q4858K
25 Q3674K
25 Q2761K
25 Q1848K
24 Q4636K
24 Q3598K
24 Q2299K
24 Q10
Net Income (USD) · TTM
-100M-50M050M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RLYB Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q245.55M
26 Q1-7.82M
25 Q4-8.98M
25 Q3-14.17M
25 Q2-41.65M
25 Q1-48.19M
24 Q4-57.77M
24 Q3-66.97M
24 Q2-73.88M
24 Q1-76.28M
Operating Income (USD) · TTM
-100M-75M-50M-25M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RLYB Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-23.72M
26 Q1-28.13M
25 Q4-33.06M
25 Q3-38.26M
25 Q2-43.4M
25 Q1-50.38M
24 Q4-60.5M
24 Q3-70M
24 Q2-77.3M
24 Q1-80.34M
EBITDA (USD) · TTM
-100M-50M050M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RLYB EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q226.96M
26 Q1-28.06M
25 Q4-32.97M
25 Q3-38.14M
25 Q2-43.28M
25 Q1-50.26M
24 Q4-60.37M
24 Q3-69.86M
24 Q2-77.16M
24 Q1-80.2M
Cash Flows (USD) · TTM
-75M-50M-25M025M50M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RLYB Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q226.34M
26 Q1-27.59M
25 Q4-29.81M
25 Q3-35M
25 Q2-41.99M
25 Q1-44.03M
24 Q4-49.28M
24 Q3-51.08M
24 Q2-54.01M
24 Q1-56.97M
EPS (USD) · TTM
-20-1001024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RLYB EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q27.8
26 Q1-1.49
25 Q4-1.71
25 Q3-2.6
25 Q2-7.52
25 Q1-8.72
24 Q4-10.8
24 Q3-12.8
24 Q2-14.32
24 Q1-15.04
Expenses (USD) · TTM
025M50M75M100MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RLYB Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q225.57M
26 Q130.18M
25 Q433.92M
25 Q338.9M
25 Q244.13M
25 Q151.16M
24 Q461.03M
24 Q370.5M
24 Q277.51M
24 Q180.29M
Shares Outstanding (USD) · TTM
-10M-7.5M-5M-2.5M0Buybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RLYB Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-2.87M
26 Q1-4.06M
25 Q4-5.32M
25 Q3-6.53M
25 Q2-7.51M
25 Q1-7.8M
24 Q4-8.01M
24 Q3-8.58M
24 Q2-9.19M
24 Q1-9.96M
Employee Count
020406020212022202320242025
RLYB Employee Count by quarter
PeriodEmployee Count
202514
202425
202343
202241
202135
PE Ratio
22.052.12.15med 2.11Aug 26Aug 26Aug 26Aug 26Sep 26Sep 26
RLYB PE Ratio by quarter
PeriodPE Ratio
Sep 262.11
Sep 262.12
Aug 262.1
Aug 262.11
Aug 262.13
Aug 262.02
Free Cash Flow Yield
-600%-400%-200%0%200%med -121.26%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
RLYB Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2627.38%
Sep 2627.3%
Aug 2627.49%
Aug 2627.46%
Aug 2627.2%
Aug 2628.6%
Jul 26-30.44%
Jul 26-29.73%
Jul 26-29.53%
Jul 26-30.83%
Jul 26-30.65%
Jun 26-30.31%
Jun 26-30.37%
Jun 26-30.46%
Jun 26-30.4%
May 26-33.54%
May 26-30.54%
May 26-33.91%
May 26-39.24%
May 26-59.97%
Apr 26-65.39%
Apr 26-68.65%
Apr 26-66.86%
Apr 26-66.94%
Mar 26-68.65%
Mar 26-63.62%
Mar 26-65.4%
Mar 26-56.95%
Feb 26-82.41%
Feb 26-122.79%
Feb 26-128.91%
Feb 26-130.81%
Jan 26-120.88%
Jan 26-115.71%
Jan 26-118.35%
Jan 26-109.39%
Jan 26-109.78%
Dec 25-112.97%
Dec 25-98.94%
Dec 25-106.03%
Dec 25-117.46%
Nov 25-119.26%
Nov 25-123.77%
Nov 25-121.36%
Nov 25-124.27%
Oct 25-134.26%
Oct 25-153.51%
Oct 25-175.04%
Oct 25-183.17%
Oct 25-165.74%
Sep 25-170.26%
Sep 25-159.06%
Sep 25-155.75%
Sep 25-153.83%
Aug 25-174.63%
Aug 25-149.53%
Aug 25-155.1%
Aug 25-176.27%
Aug 25-183.81%
Jul 25-197.17%
Jul 25-228.69%
Jul 25-242.06%
Jul 25-295.75%
Jun 25-295.75%
Jun 25-321.1%
Jun 25-303.74%
Jun 25-248.95%
May 25-318.5%
May 25-299.12%
May 25-280.96%
May 25-336.19%
May 25-347.55%
Apr 25-363.28%
Apr 25-441.39%
Apr 25-441.39%
Apr 25-245.22%
Mar 25-172.42%
Mar 25-164.7%
Mar 25-174.46%
Mar 25-154%
Feb 25-158.53%
Feb 25-151.96%
Feb 25-151.96%
Feb 25-135.75%
Jan 25-133.19%
Jan 25-130.16%
Jan 25-130.9%
Jan 25-121.85%
Jan 25-113.41%
Dec 24-125.35%
Dec 24-120.57%
Dec 24-106.06%
Dec 24-108.06%
Nov 24-97.9%
Nov 24-112.29%
Nov 24-115.55%
Nov 24-114.54%
Nov 24-121.17%
Oct 24-118.82%
Oct 24-109.27%
Price to Sales
050100150200med 50.62Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
RLYB Price to Sales by quarter
PeriodPrice to Sales
Sep 26148.92
Sep 26149.36
Aug 26148.3
Aug 26148.48
Aug 26149.89
Aug 26142.57
Jul 26105.62
Jul 26108.14
Jul 26108.87
Jul 26104.29
Jul 26104.89
Jun 26106.08
Jun 26105.88
Jun 26105.55
Jun 26105.75
May 2695.87
May 26105.29
May 2694.81
May 2688.55
May 2657.94
Apr 2653.14
Apr 2650.62
Apr 2651.97
Apr 2651.91
Mar 2650.62
Mar 2654.62
Mar 2679.39
Mar 2691.17
Feb 2663.01
Feb 2642.28
Feb 2640.28
Feb 2639.69
Jan 2642.95
Jan 2644.87
Jan 2643.87
Jan 2647.47
Jan 2647.3
Dec 2545.96
Dec 2552.48
Dec 2548.97
Dec 2544.21
Nov 2543.54
Nov 2541.95
Nov 2542.79
Nov 2541.78
Oct 2541.1
Oct 2535.94
Oct 2531.52
Oct 2530.12
Oct 2533.29
Sep 2532.41
Sep 2534.69
Sep 2535.43
Sep 2535.87
Aug 2531.6
Aug 2536.9
Aug 2535.58
Aug 2531.3
Aug 2528.25
Jul 2526.33
Jul 2522.7
Jul 2521.45
Jul 2517.56
Jun 2517.56
Jun 2516.17
Jun 2517.09
Jun 2520.86
May 2516.3
May 2517.36
May 2518.48
May 2515.44
May 2522.3
Apr 2521.33
Apr 2517.56
Apr 2517.56
Apr 2531.6
Mar 2544.94
Mar 2547.05
Mar 2544.41
Mar 2555.46
Feb 2553.88
Feb 2556.21
Feb 2556.21
Feb 2562.92
Jan 2564.13
Jan 2565.62
Jan 2565.25
Jan 2570.1
Jan 2575.32
Dec 2468.14
Dec 2470.84
Dec 2480.54
Dec 2479.04
Nov 2487.25
Nov 2476.06
Nov 2473.92
Nov 2474.57
Nov 24149.06
Oct 24152.01
Oct 24165.3
EV/EBITDA
-0.0500.050.10.15med 0.12Aug 26Aug 26Aug 26Aug 26Sep 26Sep 26
RLYB EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 260.12
Sep 260.13
Aug 260.11
Aug 260.11
Aug 260.15
Aug 26-0.03
Price/Operating Cashflow
3.453.53.553.63.653.7med 3.65Aug 26Aug 26Aug 26Aug 26Sep 26Sep 26
RLYB Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 263.65
Sep 263.66
Aug 263.64
Aug 263.64
Aug 263.68
Aug 263.5
Price to Book
00.511.52med 0.56Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
RLYB Price to Book by quarter
PeriodPrice to Book
Sep 261.02
Sep 261.02
Aug 261.01
Aug 261.02
Aug 261.02
Aug 260.97
Jul 261.8
Jul 261.85
Jul 261.86
Jul 261.78
Jul 261.79
Jun 261.81
Jun 261.81
Jun 261.8
Jun 261.8
May 261.64
May 261.8
May 261.62
May 261.31
May 260.86
Apr 260.79
Apr 260.75
Apr 260.77
Apr 260.77
Mar 260.75
Mar 260.81
Mar 260.85
Mar 260.97
Feb 260.67
Feb 260.45
Feb 260.43
Feb 260.42
Jan 260.46
Jan 260.48
Jan 260.47
Jan 260.51
Jan 260.51
Dec 250.49
Dec 250.56
Dec 250.52
Dec 250.47
Nov 250.47
Nov 250.45
Nov 250.46
Nov 250.45
Oct 250.68
Oct 250.6
Oct 250.52
Oct 250.5
Oct 250.55
Sep 250.54
Sep 250.57
Sep 250.59
Sep 250.59
Aug 250.52
Aug 250.61
Aug 250.59
Aug 250.52
Aug 250.44
Jul 250.41
Jul 250.36
Jul 250.34
Jul 250.28
Jun 250.28
Jun 250.25
Jun 250.27
Jun 250.33
May 250.26
May 250.27
May 250.29
May 250.24
May 250.23
Apr 250.22
Apr 250.18
Apr 250.18
Apr 250.33
Mar 250.46
Mar 250.49
Mar 250.46
Mar 250.47
Feb 250.45
Feb 250.47
Feb 250.47
Feb 250.53
Jan 250.54
Jan 250.55
Jan 250.55
Jan 250.59
Jan 250.64
Dec 240.58
Dec 240.6
Dec 240.68
Dec 240.67
Nov 240.74
Nov 240.64
Nov 240.62
Nov 240.63
Nov 240.56
Oct 240.57
Oct 240.62
Rallybio Corporation
RLYB
Stockpicker

Video analysis: RLYB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: RLYB

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.